These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

640 related articles for article (PubMed ID: 9565007)

  • 1. Patients with nonvalvular atrial fibrillation at low risk of stroke during treatment with aspirin: Stroke Prevention in Atrial Fibrillation III Study. The SPAF III Writing Committee for the Stroke Prevention in Atrial Fibrillation Investigators.
    JAMA; 1998 Apr 22-29; 279(16):1273-7. PubMed ID: 9565007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors associated with ischemic stroke during aspirin therapy in atrial fibrillation: analysis of 2012 participants in the SPAF I-III clinical trials. The Stroke Prevention in Atrial Fibrillation (SPAF) Investigators.
    Hart RG; Pearce LA; McBride R; Rothbart RM; Asinger RW
    Stroke; 1999 Jun; 30(6):1223-9. PubMed ID: 10356104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomised clinical trial.
    Lancet; 1996 Sep; 348(9028):633-8. PubMed ID: 8782752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: Stroke Prevention in Atrial Fibrillation II Study.
    Lancet; 1994 Mar; 343(8899):687-91. PubMed ID: 7907677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The efficacy of aspirin in patients with atrial fibrillation. Analysis of pooled data from 3 randomized trials. The Atrial Fibrillation Investigators.
    Arch Intern Med; 1997 Jun; 157(11):1237-40. PubMed ID: 9183235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selecting patients with atrial fibrillation for anticoagulation: stroke risk stratification in patients taking aspirin.
    Gage BF; van Walraven C; Pearce L; Hart RG; Koudstaal PJ; Boode BS; Petersen P
    Circulation; 2004 Oct; 110(16):2287-92. PubMed ID: 15477396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation: an individual patient meta-analysis.
    van Walraven C; Hart RG; Singer DE; Laupacis A; Connolly S; Petersen P; Koudstaal PJ; Chang Y; Hellemons B
    JAMA; 2002 Nov; 288(19):2441-8. PubMed ID: 12435257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and Economic Implications of Apixaban Versus Aspirin in the Low-Risk Nonvalvular Atrial Fibrillation Patients.
    Lip GY; Lanitis T; Mardekian J; Kongnakorn T; Phatak H; Dorian P
    Stroke; 2015 Oct; 46(10):2830-7. PubMed ID: 26316345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risks and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation: an exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) trials.
    Flaker GC; Gruber M; Connolly SJ; Goldman S; Chaparro S; Vahanian A; Halinen MO; Horrow J; Halperin JL;
    Am Heart J; 2006 Nov; 152(5):967-73. PubMed ID: 17070169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Atrial fibrillation and thromboembolic events prevention. State of the art].
    Matteoli S; Trappolini M; Chillotti FM
    Minerva Cardioangiol; 2001 Feb; 49(1):1-13. PubMed ID: 11279381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stroke risk and efficacy of apixaban in atrial fibrillation patients with moderate chronic kidney disease.
    Eikelboom JW; Connolly SJ; Gao P; Paolasso E; De Caterina R; Husted S; O'Donnell M; Yusuf S; Hart RG
    J Stroke Cerebrovasc Dis; 2012 Aug; 21(6):429-35. PubMed ID: 22818021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bleeding during antithrombotic therapy in patients with atrial fibrillation. The Stroke Prevention in Atrial Fibrillation Investigators.
    Arch Intern Med; 1996 Feb; 156(4):409-16. PubMed ID: 8607726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of thromboembolic events in atrial fibrillation.
    Koefoed BG; Gulløv AL; Petersen P
    Thromb Haemost; 1997 Jul; 78(1):377-81. PubMed ID: 9198182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of three schemes for stratifying stroke risk in patients with nonvalvular atrial fibrillation.
    Pearce LA; Hart RG; Halperin JL
    Am J Med; 2000 Jul; 109(1):45-51. PubMed ID: 10936477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of stroke in paroxysmal versus sustained atrial fibrillation in patients taking oral anticoagulation or combined antiplatelet therapy: an ACTIVE W Substudy.
    Hohnloser SH; Pajitnev D; Pogue J; Healey JS; Pfeffer MA; Yusuf S; Connolly SJ;
    J Am Coll Cardiol; 2007 Nov; 50(22):2156-61. PubMed ID: 18036454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apixaban versus aspirin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a predefined subgroup analysis from AVERROES, a randomised trial.
    Diener HC; Eikelboom J; Connolly SJ; Joyner CD; Hart RG; Lip GY; O'Donnell M; Hohnloser SH; Hankey GJ; Shestakovska O; Yusuf S;
    Lancet Neurol; 2012 Mar; 11(3):225-31. PubMed ID: 22305462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks.
    Aguilar M; Hart R
    Cochrane Database Syst Rev; 2005 Oct; (4):CD001925. PubMed ID: 16235290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-dose aspirin for prevention of stroke in low-risk patients with atrial fibrillation: Japan Atrial Fibrillation Stroke Trial.
    Sato H; Ishikawa K; Kitabatake A; Ogawa S; Maruyama Y; Yokota Y; Fukuyama T; Doi Y; Mochizuki S; Izumi T; Takekoshi N; Yoshida K; Hiramori K; Origasa H; Uchiyama S; Matsumoto M; Yamaguchi T; Hori M;
    Stroke; 2006 Feb; 37(2):447-51. PubMed ID: 16385088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of clopidogrel plus aspirin for stroke prevention in patients with atrial fibrillation in whom warfarin is unsuitable.
    Coleman CI; Straznitskas AD; Sobieraj DM; Kluger J; Anglade MW
    Am J Cardiol; 2012 Apr; 109(7):1020-5. PubMed ID: 22221944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of stroke in atrial fibrillation: an update.
    Hart RG
    Health Rep; 1994; 6(1):126-31. PubMed ID: 7919069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.